News

Article March 11, 2024

Gladstone to Expand Stem Cell Research Capabilities with Multi-Million Dollar Regenerative Medicine Grant

Funds from the California Institute for Regenerative Medicine will allow Gladstone to bolster its disease-modeling technologies, add robust CRISPR screening capabilities, and educate young researchers on the latest in stem cell science.

Grants Assay Development and Drug Discovery Core Bioinformatics Core Stem Cell Core CRISPR/Gene Editing Disease Models Organoids Regenerative Medicine Stem Cells/iPSCs

Article March 27, 2023

Meet Gladstone: Ritu Kumar

Ritu Kumar, director of the Stem Cell Core, describes her research at Gladstone, the women who have mentored her throughout her career, and the changes she'd like to see for women in STEM

Womens Initiative Profile Stem Cell Core

Article November 22, 2022

15 Years Later: This Is How Scientists Are Using Induced Pluripotent Stem Cells

Gladstone researchers talk about the power of iPS cells in biomedical research

Stem Cells/iPSCs Cardiovascular Disease Stem Cell Core

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids

Article November 20, 2019

Machine, Meet Stem Cells

Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.

News Release Research (Publication) Histology and Light Microscopy Core Stem Cell Core Conklin Lab McDevitt Lab AI Big Data CRISPR/Gene Editing Imaging

Article October 8, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Stem Cell Core Huntington’s Disease Alzheimer’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing

Article March 30, 2018

Meet Gladstone: Wendy Runyon

Wendy explains how being rejected for a lab position led her to work in what she describes as “zookeeping for cells.” She also talks about her Masters Swimming skills and how she developed her secret talent for cake decoration.

Profile Stem Cell Core Stem Cells/iPSCs